The ground floor, Level 1, is dedicated to manufacturing, featuring independent material loading and unloading areas, an advanced HVAC system for air quality control, and a robust water distribution system. Comprehensive firefighting equipment is available on this level, underscoring HPL’s commitment to operational safety.

The Inhaler Manufacturing Unit is certified for Good Manufacturing Practices (GMP) by the Directorate General of Drug Administration (DGDA), Ministry of Health & Family Welfare, Government of Bangladesh.

The Inhaler Manufacturing Unit specializes in the production of Metered Dose Inhalers (MDI) and Dry Powder Inhalers (DPI). Equipped with state-of-the-art pharmaceutical technology, this unit is operated by a highly skilled team dedicated to upholding the highest standards of product quality and safety. The advanced HVAC system ensures stringent environmental control, crucial for the production of inhalation products that require consistent air quality and cleanliness to maintain product integrity.

HPL’s Quality Management System (QMS) within the Inhaler Manufacturing Unit adheres to internationally recognized guidelines, including EudraLex Volume 4 and 21 CFR 210 & 211. The QMS encompasses critical processes such as Deviation Management, Change Control, Quality Risk Management, and Corrective and Preventive Actions (CAPA), with all activities monitored through digital platforms like eQMS, DMS, and LMS. Finished products are released via SAP, ensuring traceability and accountability at every stage.

The unit is supported by a dedicated Research and Development (R&D) team focused on local product development, ensuring alignment with the latest guidelines and innovations in inhaler technology. This commitment to continuous improvement and research reinforces HPL’s mission to deliver safe, reliable inhalation products that enhance patient outcomes.

With advanced technology, a skilled workforce, and adherence to rigorous quality standards, HPL’s Inhaler Manufacturing Unit is positioned as a leader in the inhaler product segment, dedicated to producing effective, high-quality inhalation therapies for patients around the world.